Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M File

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
Expert Review of Anti-Infective Therapy|November 30, 2004
Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infectionsThomas M File, Glenn S Tillotson
Nature Clinical Practice. Rheumatology|December 7, 2007
Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?Thomas M File, Elizabeth A File
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2019
Early Steps Toward Ambulatory Antimicrobial Stewardship: Dental and Orthopedic FocusThomas M File, Susan C Bleasdale
The New England Journal of Medicine|August 16, 2023
Community-Acquired PneumoniaThomas M File, Julio A Ramirez
Infectious Disease Clinics of North America|February 13, 2013
Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?Thomas M File, Thomas J Marrie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Performance measurement in community-acquired pneumonia: consequences intended and unintendedThomas M File, Peter A Gross
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumoniaThomas M File, Jerome J Schentag
Current Opinion in Infectious Diseases|May 15, 2007
How long should we treat community-acquired pneumonia?Nikole M Scalera, Thomas M File
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial PneumoniaRichard R Watkins, Thomas M File
Clinics in Geriatric Medicine|July 10, 2016
Bacterial Pneumonia in Older AdultsThomas J Marrie, Thomas M File
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
Expert Review of Anti-Infective Therapy|November 30, 2004
Gemifloxacin: a new, potent fluoroquinolone for the therapy of lower respiratory tract infectionsThomas M File, Glenn S Tillotson
Nature Clinical Practice. Rheumatology|December 7, 2007
Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?Thomas M File, Elizabeth A File
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 16, 2019
Early Steps Toward Ambulatory Antimicrobial Stewardship: Dental and Orthopedic FocusThomas M File, Susan C Bleasdale
The New England Journal of Medicine|August 16, 2023
Community-Acquired PneumoniaThomas M File, Julio A Ramirez
Infectious Disease Clinics of North America|February 13, 2013
Does empiric therapy for atypical pathogens improve outcomes for patients with CAP?Thomas M File, Thomas J Marrie
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Performance measurement in community-acquired pneumonia: consequences intended and unintendedThomas M File, Peter A Gross
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumoniaThomas M File, Jerome J Schentag
Current Opinion in Infectious Diseases|May 15, 2007
How long should we treat community-acquired pneumonia?Nikole M Scalera, Thomas M File
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2020
Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial PneumoniaRichard R Watkins, Thomas M File
Clinics in Geriatric Medicine|July 10, 2016
Bacterial Pneumonia in Older AdultsThomas J Marrie, Thomas M File
Pageof 16